Further, the signaling pathway went downstream to high mobility group box-1 (HMGB1)/phosphoinositide-3-kinase (PI3K)/AKT and the proliferative and metastatic abilities of breast cancer cells were enhanced as a consequence [60]. This evidence concerns the gene HMGB1 and breast cancer.